AstraZeneca PLC
13 November 2003
DEALING BY DIRECTORS
COMPANIES ACT 1985 SECTIONS 324/329
WE HEREBY INFORM YOU THAT, ON 13 NOVEMBER 2003, SIR TOM MCKILLOP, A DIRECTOR OF
THE COMPANY BECAME BENEFICIALLY ENTITLED TO 1,378 ASTRAZENECA PLC ORDINARY
SHARES OF USD0.25 EACH. THE SHARES WERE ALLOCATED TO SIR TOM MCKILLOP ON 16
NOVEMBER 2000 AND HAVE BEEN HELD IN TRUST SINCE THEN IN ACCORDANCE WITH THE
ARRANGEMENTS ANNOUNCED AT THAT TIME. ON 13 NOVEMBER 2003 THE COMPANY SOLD 567
OF THE SAID SHARES AT A PRICE OF 2765 PENCE PER SHARE ON BEHALF OF SIR TOM
MCKILLOP IN ORDER TO MEET AN IMMEDIATE INCOME TAX LIABILITY ARISING ON THE
RELEASE OF THE SHARES. FOLLOWING THIS SALE, SIR TOM MCKILLOP HAS A TOTAL
INTEREST IN 77,835 ORDINARY SHARES, WHICH REPRESENTS APPROXIMATELY 0.005 PER
CENT OF THE NUMBER OF SHARES CURRENTLY IN ISSUE.
G H R MUSKER
COMPANY SECRETARY
13 NOVEMBER 2003
This information is provided by RNS
The company news service from the London Stock Exchange ND
RDSBLBDBDDBGGXX
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.